| 标题 |
Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition |
| 网址 | |
| DOI | |
| 其它 | Ramacciotti E, Weitz JI. Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition. Thromb Res. 2019 Dec;184:44-49. doi: 10.1016/j.thromres.2019.09.033. Epub 2019 Oct 23. PMID: 31706067. |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)